Certain anatomical properties of the brain – not the initial injury – determine most of a patient’s risk of developing chronic pain, according to a new study.
Genetic mutations that cause neuropsychiatric disorders may make synapses smaller and weaker, according to a new Northwestern Medicine study.
Northwestern Medicine scientists mapped brain circuitry associated with addiction and reward, and found that smoking affects the way the brain relates and responds to pain. The findings could lead to targeted therapies for chronic pain sufferers.
Northwestern Medicine scientists have proven an old therapeutic focus for Huntington’s disease wrong, and they propose a new one in its place.
The experimental drug prolonged the lifespan in a mouse model of accelerated aging by inhibiting a protein that plays a key role in the process.
Tanya Simuni, MD, was awarded a grant from the National Institutes of Health to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson’s disease.
Acclaimed physiologist and expert in the biomechanics of skeletal muscle will arrive at the Rehabilitation Institute of Chicago and Northwestern University Feinberg School of Medicine later this year.
Lauren Smith, a sixth-year MD/PhD student, is the recipient of a Presidential Fellowship, the most prestigious fellowship awarded to graduate students at Northwestern. Her research focuses on improving the control of myoelectric upper limb prostheses. She works in the labs of Todd Kuiken, MD, PhD, and Levi Hargrove, PhD.
With its recent renewal, Feinberg’s Udall Center of Excellence for Parkinson’s Disease Research is one of 10 such centers funded by the National Institute of Neurological Disorders and Stroke.
Anis Contractor, PhD, associate professor in Physiology, recently published findings on what causes delays in synaptic and neuronal development in the cortex, hallmarks of fragile X syndrome, the most common known cause of autism.